Company
Orakl Oncology
- AI
- Biotech
- Location:
- Villejuif, France
Description
Orakl Oncology builds an AIxBio engine that analyzes multimodal patient data and living biological samples to predict drug responses, identify therapeutic targets, and support clinical trial design for oncology applications.
Orakl Oncology is located in the Paris ecosystem.
Related
ScientaLabScientaLab develops a foundation model that predicts human immune response in immunology and inflammation, using multi-disease,…
Qubit PharmaceuticalsQubit Pharmaceuticals develops quantum- and AI-driven molecular modeling platforms and drug discovery tools used to design novel drug…
Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…
deCODE geneticsdeCODE genetics operates a human gene-discovery engine that analyzes population-scale genomic data to identify genetic risk factors and…
- RiviaRivia provides a unified intelligence layer that ingests and harmonizes fragmented clinical trial data, applies structured trial models,…
Neuralk-AINeuralk-AI provides a tabular foundation model accessible via an API that predicts targets on structured datasets without training or…
THETA BiomarkersTHETA Biomarkers analyzes fluid and tissue samples through bioanalytical and metabolomics tests, combining sample analysis with biochemical…
IktosIktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis…
Cumulus NeuroscienceCumulus Neuroscience delivers NeuLogiq for CNS clinical studies, using multimodal digital assessments to monitor discrete brain functions…